Gynecologic Cancer
Nine important updates for Gynecologic Cancer Awareness Month
September is Gynecologic Cancer Awareness Month, an awareness campaign launched in 1999 by Foundation for Women’s Cancer.
Top in hem/onc: Tagrisso, gynecologic cancer, hospital rankings
The FDA has granted breakthrough therapy designation to osimertinib for certain patients with early-stage non-small cell lung cancer. It was the top story in hematology/oncology last week.
Roswell Park Comprehensive Cancer Center promotes three staff members to leadership roles
Roswell Park Comprehensive Caner Center appointed three staff members within its department of gynecologic oncology to leadership roles.
Minimally invasive surgery may increase risk for death in early-stage gynecologic cancers
Minimally invasive surgical procedures appeared associated with an elevated risk for recurrence or death vs. open surgery among women with early-stage gynecologic cancers, according to results of two studies published in JAMA Oncology.
Top stories in hematology/oncology: Impact of screening on fatal breast cancer risk, Disney movies help women undergoing chemotherapy
Results of a retrospective study demonstrated a 41% reduction in the risk for fatal breast cancer within 10 years of diagnosis among women who underwent mammography screening compared with those who did not receive screening. This was the top story in hematology/oncology last week.
Q&A: How the COVID-19 pandemic affects women’s health
During the COVID-19 pandemic, physicians across the United States have reported seeing fewer patients, who are fearful of presenting to the office due to the virus.
Watching Disney movies during chemotherapy may improve quality of life for women with gynecologic cancer
Just a spoonful of sugar from Mary Poppins during cancer treatment might have an effect, after all.
Younger women with gynecologic cancers at high risk for osteoporosis 1 year after treatment
Women aged 65 years or younger who underwent surgery and adjuvant chemotherapy for gynecologic cancer appeared at higher risk for osteopenia and osteoporosis as early as 1 year after treatment, according to study results presented at the virtual Society of Gynecologic Cancer Annual Meeting.
Potential OB-GYN shortfall in US presents serious public health challenge
Researchers found that 35% of OB-GYNs across the U.S. are aged 55 years or older, but only 19% of OB-GYNs are aged younger than 40 years — findings that point to a potential shortage of these physicians in the coming years.